ICM
ACHC icon

Invenomic Capital Management’s Acadia Healthcare ACHC Stock Holding History

Invenomic Capital Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7M Sell
1,182,331
-2,129,712
-64% -$38.6M 1.27% 26
2025
Q4 		$47M Buy
3,312,043
+1,375,647
+71% +$26M 2.19% 7
2025
Q3 		$47.9M Buy
1,936,396
+568,796
+42% +$12.7M 2.32% 7
2025
Q2 		$31M Buy
1,367,600
+1,295,821
+1,805% +$30.7M 1.76% 12
2025
Q1 		$2.18M Buy
+71,779
New +$2.73M 0.11% 150

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invenomic Capital Management's ACHC Position: Q1 2026 in Review

Invenomic Capital Management reduced its Acadia Healthcare (ACHC) stake by 64% in Q1 2026, selling an estimated $38.6M and leaving 1,182,331 shares worth $27.7M. The position accounts for 1.27% of the portfolio, ranked #26.

Invenomic Capital Management first reported a position in ACHC in Q1 2025 and has held it in 5 quarters since. The position peaked at $47.9M in Q3 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Invenomic Capital Management held 1,182,331 shares of Acadia Healthcare worth $27.7M as of Q1 2026.
  • Invenomic Capital Management sold 2,129,712 Acadia Healthcare shares in Q1 2026, an estimated $38.6M.
  • Acadia Healthcare made up 1.27% of Invenomic Capital Management's portfolio in Q1 2026, its #26 holding.
  • Invenomic Capital Management first reported a position in Acadia Healthcare in Q1 2025 and has held it in 5 quarters since.
  • Invenomic Capital Management's Acadia Healthcare position peaked at $47.9M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.